Vaxcyte, Inc. PCVX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s net change in cash?
- Vaxcyte, Inc. (PCVX) reported net change in cash of $86.88M in Q1 2026.
- How has Vaxcyte, Inc.'s net change in cash changed year-over-year?
- Vaxcyte, Inc.'s net change in cash increased by 311.8% year-over-year, from -$41.03M to $86.88M.
- What is the long-term trend for Vaxcyte, Inc.'s net change in cash?
- Over 3 years (2021 to 2025), Vaxcyte, Inc.'s net change in cash has grown at a -12.2% compound annual growth rate (CAGR), from -$316.34M to -$213.77M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.